Corestreet Logo

Theravance Biopharma Inc (TBPH) Insider Trading

Total insider buys:
  • $29,986,863,717,436.00
Total insider sells:
  • $8,552,174.31
Most recent insider trade:
  • Aug. 7, 2024
Most active insider trader:
  • Richard A Graham
Trader NameDateTitleAmountPriceTypeTotal Value
Aug. 7, 2024Major Shareholder999,800$7.80Buy$7,798,440.00
July 10, 2024SVP4,000$9.00Sell$36,000.00
Feb. 22, 2024SVP1,254$8.71Sell$10,922.34
Nov. 21, 2023SVP1,378$10.29Sell$14,179.62
Nov. 14, 2023SVP2,482$10.22Sell$25,366.04
Oct. 16, 2023SVP2,482$9.03Sell$22,412.46
Sept. 14, 2023SVP2,482$9.89Sell$24,546.98
Aug. 22, 2023SVP1,807$9.47Sell$17,112.29
Aug. 11, 2023SVP2,322$9.99Sell$23,196.78
July 14, 2023SVP2,322$9.84Sell$22,848.48
June 14, 2023SVP2,322$10.69Sell$24,822.18
June 8, 2023SVP1,790$11.13Sell$19,922.70
May 15, 2023SVP2,322$11.26Sell$26,145.72
April 14, 2023SVP2,323$11.88Sell$27,597.24
March 14, 2023SVP2,323$10.32Sell$23,973.36
March 9, 2023SVP4,000$10.20Sell$40,800.00
March 6, 2023SVP2,323$10.05Sell$23,346.15
Dec. 14, 2022CEO50,000$11.19Sell$559,500.00
Dec. 1, 2022SVP2,084$10.73Sell$22,361.32
Aug. 16, 2022SVP4,906$9.71Sell$47,637.26
Aug. 9, 2022SVP15,086$8.79Sell$132,605.94
May 23, 2022SVP1,081$8.93Sell$9,653.33
Feb. 28, 2022SVP2,356$10.16Sell$23,936.96
March 9, 2021SVP8,829$20.00Sell$176,580.00
Dec. 14, 2020SVP7,500$19.47Sell$146,025.00
Dec. 3, 2020SVP4,246$18.00Sell$76,428.00
Aug. 21, 2020Insider25,000$18.29Sell$457,250.00
Aug. 20, 2020SVP17,103$18.00Sell$307,854.00
Dec. 12, 2019SVP1,027$21.03Sell$21,597.81
May 17, 2019Director4,000$20.46Sell$81,840.00
March 5, 2019SVP9,033$24.71Sell$223,205.43
Sept. 12, 2018SVP6,393$28.50Sell$182,200.50
Aug. 27, 2018EVP7,119$27.71Sell$197,267.49
Aug. 15, 2018CFO43,743$26.79Sell$1,171,874.97
Aug. 8, 2018EVP31,300$27.94Sell$874,522.00
June 8, 2018EVP14,040$23.97Sell$336,538.80
June 6, 2018EVP10,140$24.09Sell$244,272.60
May 21, 2018Director1,000$22.54Buy$22,540.00
May 18, 2018CFO10,000$24.29Sell$242,900.00
Sept. 6, 2017EVP14,670$30.77Sell$451,395.90
Aug. 21, 2017SVP4,000$26.34Buy$105,360.00
Aug. 11, 2017Director6,000$23.99Buy$143,940.00
Aug. 11, 2017CEO10,000$24.50Buy$245,000.00
March 7, 2017SVP424$30.80Sell$13,059.20
March 6, 2017SVP13,576$31.52Sell$427,915.52
Aug. 25, 2016SVP4,491$27.99Sell$125,703.09
Aug. 22, 2016EVP49,122$27.46Sell$1,348,890.12
Aug. 19, 2016SVP9,509$27.97Sell$265,966.73
March 14, 2016Major Shareholder1,301,015$23,028,000.00Buy$29,959,773,420,000.00
Oct. 7, 2015Major Shareholder44,574$607,544.00Buy$27,080,666,256.00
First«1 of 2»Last

  • Insiders are both buying and selling Theravance Biopharma Inc stock.

  • The insider traders at Theravance Biopharma Inc are: Richard A Graham, Rhonda Farnum, Bradford J Shafer, Brett K Haumann, Philip D Worboys, Rick E Winningham, Renee D Gala, Burton G Malkiel, Plc Glaxosmithkline, Donal O'connor, Sharathchandra S Hegde, Frank Pasqualone, Vijay Sabesan, Henrietta Fore, Junning Lee, and Eli Samaha

  • The most active insider trader at Theravance Biopharma Inc is Richard A Graham with 14 trades.

  • Bradford J Shafer has sold the most Theravance Biopharma Inc stock with a total value of $3,650,154.40.

  • Plc Glaxosmithkline has bought the most Theravance Biopharma Inc stock with a total value of $59,946,627,506,256.00.

  • The most recent insider trade for Theravance Biopharma Inc was on Aug. 7, 2024.

  • The single biggest insider buy for Theravance Biopharma Inc was from Plc Glaxosmithkline with a total value of $29,959,773,420,000.00 on March 14, 2016.

  • The single biggest insider sell for Theravance Biopharma Inc was from Bradford J Shafer with a total value of $1,348,890.12 on Aug. 22, 2016.